David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$826M |
| 2 |
Microsoft
MSFT
|
+$549M |
| 3 |
Pinduoduo
PDD
|
+$305M |
| 4 |
Intel
INTC
|
+$274M |
| 5 |
Apple
AAPL
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$382M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$298M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$267M |
| 4 |
Procter & Gamble
PG
|
+$260M |
| 5 |
Meta Platforms (Facebook)
META
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.35% |
| 2 | Healthcare | 8.99% |
| 3 | Financials | 7.94% |
| 4 | Consumer Discretionary | 7.49% |
| 5 | Industrials | 4.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Arcosa
ACA
$7.14B
| $1.62M | ﹤0.01% |
29,904
-43,230
| -59% | -$2.57M |
|
2952
Amphastar Pharmaceuticals
AMPH
$924M
| $1.62M | ﹤0.01% |
57,948
+69
| +0.1% | +$2K |
|
2953
Lithia Motors
LAD
$8.1B
| $1.62M | ﹤0.01% |
7,921
-11,455
| -59% | -$2.45M |
|
|
HSKA
2954
DELISTED
Heska Corp
HSKA
| $1.62M | ﹤0.01% |
26,052
+17,008
| +188% | +$1.15M |
|
2955
PUT
Invesco
IVZ
$14.8B
| $1.62M | ﹤0.01% |
90,000
-60,400
| -40% | -$1.03M |
|
2956
Clearwater Paper
CLW
$339M
| $1.62M | ﹤0.01% |
42,807
-21,750
| -34% | -$848K |
|
|
ENER
2957
DELISTED
Accretion Acquisition Corp
ENER
| $1.62M | ﹤0.01% |
160,525
| – | – |
|
2958
Prothena Corp
PRTA
$467M
| $1.62M | ﹤0.01% |
26,856
-78,374
| -74% | -$4.59M |
|
|
TARO
2959
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $1.62M | ﹤0.01% |
55,652
+403
| +0.7% | +$12K |
|
2960
CALL
Amkor Technology
AMKR
$12.7B
| $1.61M | ﹤0.01% |
+67,300
| New | +$1.56M |
|
2961
Brookfield Renewable
BEPC
$6.08B
| $1.61M | ﹤0.01% |
58,568
+37,203
| +174% | +$1.15M |
|
2962
First Internet Bancorp
INBK
$241M
| $1.61M | ﹤0.01% |
66,423
+15,436
| +30% | +$408K |
|
2963
PUT
WD-40
WDFC
$2.9B
| $1.61M | ﹤0.01% |
10,000
| – | – |
|
2964
Dorman Products
DORM
$3.81B
| $1.61M | ﹤0.01% |
19,896
-10,940
| -35% | -$929K |
|
|
EGRX
2965
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.61M | ﹤0.01% |
54,917
+1,023
| +2% | +$32.5K |
|
2966
Bumble
BMBL
$366M
| $1.6M | ﹤0.01% |
76,215
-221,954
| -74% | -$5.11M |
|
2967
Harrow
HROW
$1.44B
| $1.6M | ﹤0.01% |
+108,526
| New | +$1.3M |
|
2968
Adecoagro
AGRO
$1.54B
| $1.6M | ﹤0.01% |
192,534
-341,250
| -64% | -$2.79M |
|
|
PTVE
2969
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $1.59M | ﹤0.01% |
140,389
-21,407
| -13% | -$234K |
|
|
SKYT
2970
DELISTED
SkyWater Technology
SKYT
| $1.59M | ﹤0.01% |
223,499
+130,015
| +139% | +$1.1M |
|
2971
Simmons First National
SFNC
$3.26B
| $1.59M | ﹤0.01% |
73,467
-94,432
| -56% | -$2.14M |
|
|
OLK
2972
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $1.58M | ﹤0.01% |
62,444
+12,197
| +24% | +$245K |
|
|
EWCZ
2973
DELISTED
European Wax Center
EWCZ
| $1.58M | ﹤0.01% |
127,262
+80,479
| +172% | +$1.16M |
|
2974
MiMedx Group
MDXG
$675M
| $1.58M | ﹤0.01% |
568,226
+101,289
| +22% | +$303K |
|
|
RPTX
2975
DELISTED
Repare Therapeutics
RPTX
| $1.58M | ﹤0.01% |
107,274
+41,890
| +64% | +$627K |
|
Similar funds
David Shaw's Q4 2022 Portfolio in Review
As of Q4 2022, David Shaw held 5,609 positions worth $90.5B, up 8.1% from $83.7B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
David Shaw withdrew a net $5.29B in Q4 2022, closing 783 positions and reducing 1,541 holdings. Its most notable exit was Twitter, Inc., an estimated $267M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
Against the trend, David Shaw opened a new position in iShares JPMorgan USD Emerging Markets Bond ETF worth $255M.
- David Shaw's largest Q4 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M.
- David Shaw added most to Tesla in Q4 2022, an estimated $826M increase.
- David Shaw's biggest Q4 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $382M.
- David Shaw fully exited Twitter, Inc. in Q4 2022, selling an estimated $267M.
- David Shaw's ten largest holdings make up 8.3% of its $90.5B portfolio in Q4 2022.
- David Shaw opened 475 new positions and closed 783 in Q4 2022.
- David Shaw's portfolio value rose 8.1% quarter-over-quarter to $90.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.